Clinical Trial Deaths Lead Ariad To Halt Iclusig Sales
Ariad Pharmaceuticals Inc. on Thursday suspended sales of leukemia drug Iclusig at the request of the U.S. Food and Drug Administration after more than a dozen participants in clinical trials died...To view the full article, register now.
Already a subscriber? Click here to view full article